Education
About Us
Working with TipRanks
Follow Us
Singapore Institute of Advanced Medicine Holdings Ltd. (SG:9G2)
SGX:9G2
Total Valuation
Singapore Institute of Advanced Medicine Holdings Ltd. has a market cap or net worth of ―. The enterprise value is S$86.17M.
Market Cap―
Enterprise ValueS$86.17M
Share Statistics
Singapore Institute of Advanced Medicine Holdings Ltd. has 1,231,494,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,231,494,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Singapore Institute of Advanced Medicine Holdings Ltd.’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -18.80%.
Return on Equity (ROE)-0.47
Return on Assets (ROA)-0.21
Return on Invested Capital (ROIC)-18.80%
Return on Capital Employed (ROCE)-0.21
Revenue Per Employee146.82K
Profits Per Employee-244.49K
Employee Count107
Asset Turnover0.13
Inventory Turnover11.28
Valuation Ratios
The current PE Ratio of Singapore Institute of Advanced Medicine Holdings Ltd. is ―. Singapore Institute of Advanced Medicine Holdings Ltd.’s PEG ratio is 0.04.
PE Ratio―
PS Ratio1.94
PB Ratio0.55
Price to Fair Value0.55
Price to FCF-2.83
Price to Operating Cash Flow-3.01
PEG Ratio0.04
Income Statement
In the last 12 months, Singapore Institute of Advanced Medicine Holdings Ltd. had revenue of 15.71M and earned -26.16M in profits. Earnings per share was -0.02.
Revenue15.71M
Gross Profit14.42M
Operating Income-22.35M
Pretax Income-26.15M
Net Income-26.16M
EBITDA-11.08M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -10.93M and capital expenditures -147.78K, giving a free cash flow of -11.08M billion.
Operating Cash Flow-10.93M
Free Cash Flow-11.08M
Free Cash Flow per Share>-0.01
Dividends & Yields
Singapore Institute of Advanced Medicine Holdings Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.18
52-Week Price Change-50.00%
50-Day Moving Average0.03
200-Day Moving Average0.04
Relative Strength Index (RSI)55.54
Average Volume (3m)247.96K
Important Dates
Singapore Institute of Advanced Medicine Holdings Ltd. upcoming earnings date is Aug 29, 2025, During Market Hours (Confirmed).
Last Earnings DateFeb 14, 2025
Next Earnings DateAug 29, 2025
Ex-Dividend Date―
Financial Position
Singapore Institute of Advanced Medicine Holdings Ltd. as a current ratio of 0.31, with Debt / Equity ratio of 104.62%
Current Ratio0.31
Quick Ratio0.30
Debt to Market Cap0.93
Net Debt to EBITDA-5.00
Interest Coverage Ratio-7.05
Taxes
In the past 12 months, Singapore Institute of Advanced Medicine Holdings Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Singapore Institute of Advanced Medicine Holdings Ltd. EV to EBITDA ratio is -7.75, with an EV/FCF ratio of -7.97.
EV to Sales5.47
EV to EBITDA-7.75
EV to Free Cash Flow-7.97
EV to Operating Cash Flow-8.08
Balance Sheet
Singapore Institute of Advanced Medicine Holdings Ltd. has S$2.84M in cash and marketable securities with S$58.21M in debt, giving a net cash position of -S$55.37M billion.
Cash & Marketable SecuritiesS$2.84M
Total DebtS$58.21M
Net Cash-S$55.37M
Net Cash Per Share-S$0.04
Tangible Book Value Per ShareS$0.05
Margins
Gross margin is -54.27%, with operating margin of -142.27%, and net profit margin of -166.53%.
Gross Margin-54.27%
Operating Margin-142.27%
Pretax Margin-166.48%
Net Profit Margin-166.53%
EBITDA Margin-70.50%
EBIT Margin-146.29%
Analyst Forecast
The average price target for Singapore Institute of Advanced Medicine Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-5.63%
EPS Growth Forecast30.53%